Get educational information about Ph+ CML in chronic phase and SCEMBLIX
For US residents only.
Information to help you learn about SCEMBLIX
Below are resources that provide information about SCEMBLIX. You may find it helpful to download and review these materials.
You’ll also find a list of organizations and advocacy groups that support patients with Ph+ CML.
SCEMBLIX Patient Guide
Helpful information about your disease and treatment with SCEMBLIX.Download SCEMBLIX Patient Guide
Doctor Discussion Guide
Questions to ask your doctor to see if SCEMBLIX may be right for you.Download Doctor Discussion Guide
Support and Financial Resources Guide
Learn about patient support for SCEMBLIX and ways eligible patients may be able to save on their medication.Download Support and Financial Resources Guide
SCEMBLIX Patient Information
Important Safety Information about SCEMBLIX.Download SCEMBLIX Patient Information
Reach out to others with Ph+ CML in chronic phase
Ph+ CML in chronic phase is considered a rare cancer—and it can be difficult to find other patients like yourself. The following organizations may be a helpful source of connections, information, and support.
Leukemia & Lymphoma Society®
The National CML Society
The Max Foundation
Leukemia Research Foundation
American Cancer Society®
National Cancer Institute’s Cancer Information Service
Those with TTY equipment may call 1-800-322-8615
National Patient Advocate Foundation
The organizations and websites listed on this page are maintained by third parties over whom Novartis Pharmaceuticals Corporation has no control. As such, Novartis Pharmaceuticals Corporation makes no representation as to the accuracy or any other aspect of the information supplied by these organizations or contained in these websites.
Track your CML journey
As a social network for managing and navigating cancer treatment, the Belong app connects CML patients and caregivers. It’s anonymous and free.
You can download the Belong app from Google Play or the App Store. To learn more, visit www.belong.life
Review your dosing routine and learn about monitoring from a Patient Navigator